{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:01:28Z","timestamp":1793023288977,"version":"4.5.0"},"reference-count":43,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypoglycaemia is a serious side effect in the treatment of type 2 diabetes mellitus (T2DM), especially when using insulin and insulin secretagogues such as sulfonylureas. Current guidelines recommend reducing or discontinuing these medications in high\u2010risk populations. This study assessed the real\u2010world effectiveness and safety of oral semaglutide in T2DM patients who suspended or reduced sulfonylurea dosages in favour of oral semaglutide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective, multicentre cohort study, the primary endpoint was the change in glycated haemoglobin (HbA1c) from baseline to an average follow\u2010up period of 37\u2009weeks. Secondary endpoints included changes in fasting blood glucose, body weight, the proportion of patients achieving HbA1c \u22647%, and combined reductions in HbA1c (\u22651%) and body weight (\u22655%). Safety and exploratory endpoints were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 104 patients (mean age: 68.9\u2009\u00b1\u20099.9\u2009years). Treatment discontinuation occurred in 9.6% of patients, and 12.5% reported adverse events, primarily gastrointestinal; no hypoglycaemic events were reported. HbA1c significantly decreased from 7.62% to 7.42% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04, mean reduction of 0.22%) and the proportion of patients achieving HbA1c \u22647% increased from 29.8% to 36.3%. Body weight was significantly reduced by 3.03\u2009kg (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Significant reductions (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) were observed in fasting blood sugar, waist circumference, diastolic blood pressure, total cholesterol and albumin\u2010to\u2010creatinine ratio, while HDL cholesterol and estimated glomerular filtration rate increased. The 10\u2010year cardiovascular risk score significantly decreased from 17.0% to 12.9% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Real\u2010world data suggest that oral semaglutide is an effective and safe alternative to sulfonylureas for T2DM patients, with no reported hypoglycaemic episodes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.16314","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:14:46Z","timestamp":1741713286000},"page":"3084-3093","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real\u2010world retrospective study"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8012-7295","authenticated-orcid":false,"given":"Silvana","family":"Costa","sequence":"first","affiliation":[{"name":"Diabetology and Metabolic Diseases Unit S. Bortolo Hospital  Vicenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Miranda","sequence":"additional","affiliation":[{"name":"Clinic of Endocrinology and Metabolism Diseases ASFO Pordenone Hospital  Pordenone Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Elefante","sequence":"additional","affiliation":[{"name":"UOC Malattie Endocrine e del Metabolismo Azienda Ospedaliera Regionale San Carlo  Potenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Vallone","sequence":"additional","affiliation":[{"name":"Metabolic Disease and Endocrinology Citt\u00e0 del Piave Hospital  San Don\u00e0 di Piave Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Vinci","sequence":"additional","affiliation":[{"name":"Metabolic Disease and Endocrinology Citt\u00e0 del Piave Hospital  San Don\u00e0 di Piave Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Borroni","sequence":"additional","affiliation":[{"name":"Diabetology and Metabolic Diseases Unit AST Macerata  Macerata Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Brandoni","sequence":"additional","affiliation":[{"name":"Diabetology and Metabolic Diseases Unit AST Macerata  Macerata Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Labate","sequence":"additional","affiliation":[{"name":"Specialistica Ambulatoriale Branca Diabetologia del Distretto Dell'Alto Mantovano ASST Mantova  Mantova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano","family":"Lo Pomo","sequence":"additional","affiliation":[{"name":"UOC Malattie Endocrine e del Metabolismo Azienda Ospedaliera Regionale San Carlo  Potenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Strazzabosco","sequence":"additional","affiliation":[{"name":"Diabetology and Metabolic Diseases Unit S. Bortolo Hospital  Vicenza Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"IDF Diabetes Atlas.IDF Diabetes Atlas.2021. Accessed June 18 2024.https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/"},{"key":"e_1_2_10_3_1","unstructured":"Type 2 Diabetes|International Diabetes Federation. Accessed June 18 2024.https:\/\/idf.org\/about-diabetes\/type-2-diabetes\/"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713381"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci18\u20100033"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574\u2010022\u201000690\u20107"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24\u2010S009"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23\u2010S009"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz486"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265\u2010021\u201001499\u2010w"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261\u2010019\u201000826\u20100"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12911"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(18)30315\u20102"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1152260"},{"key":"e_1_2_10_16_1","unstructured":"CollinsL CostelloRA.Glucagon\u2010like Peptide\u20101 Receptor Agonists. NCBI Bookshelf A service of the National Library of Medicine National Institutes of Health2023."},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa413"},{"key":"e_1_2_10_18_1","unstructured":"Drug Approval Package: RYBELSUS. Accessed June 21 2024.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/213051Orig1s000TOC.cfm"},{"key":"e_1_2_10_19_1","unstructured":"Rybelsus | European Medicines Agency. Accessed October 31 2023.https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rybelsus"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19\u20100749"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19\u20100883"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2942"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(19)31271\u20101"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(19)30192\u20105"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901118"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(19)30194\u20109"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19\u20100898"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(20)30075\u20109"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(20)30074\u20107"},{"key":"e_1_2_10_30_1","unstructured":"U\u2010Prevent. Accessed November 4 2024.https:\/\/u-prevent.com\/calculators\/description\/advanceScore"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24\u2010S006"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci18\u20100018"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592\u2010022\u201001857\u20104"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13113054"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186052"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010024\u201001631\u20105"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030751"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2021.0108"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa073"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164752"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010024\u201001590\u2010x"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010024\u201001614\u20106"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15493"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010024\u201001588\u20105"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.16314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:55:28Z","timestamp":1761893728000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.16314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/dom.16314"],"URL":"https:\/\/doi.org\/10.1111\/dom.16314","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.16314\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v1\/review4","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16314\/v1\/review3","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"2025-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}